ArticleThe Laryngoscope2026
Cricothyroid Approximation in Trans Women With Type A Cricothyroid Joints.
Article in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cricothyroid Approximation in Trans Women With Type A Cricothyroid Joints.The Laryngoscope · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveIn trans women, low-pitched voice can be raised by cricothyroid approximation (CTA). The aim of the study was to analyze voice outcomes in trans women with Type A cricothyroid joints (CTJs) over a period of 5 years. STUDY
designProspective cohort study.
methodsThirty-five trans women were included in the study after high-resolution computed tomography evaluation revealed a Type A CTJ (Type A: well-defined facet; B: no definable facet; C: flat cartilage surface). All had voice therapy before CTA. Additionally, voice assessment (mean speaking level [MSL], loudness, vocal range of speaking voice, Trans Women Voice Questionnaire [TWVQ]) was performed before and after voice therapy, and after CTA at 4 weeks, 6 months, and 1 year, and then annually for 5 years.
resultsMSL rose with voice therapy from 134 to 150 Hz. With CTA, the MSL increased to 184 Hz 4 weeks postoperatively and to 199 Hz 6 months postoperatively. The MSL has remained stable at 203-209 Hz for 5 years. The TWVQ score decreased from 91 to 84 patients with voice therapy. After CTA, it decreased to 50 patients and has remained stable for 5 years.
conclusionCTA in trans women with Type A CTJ is a valuable technique for elevating MSL, providing stable results for 5 years. Therefore, CTA should only be performed in patients with Type A CTJs who desire higher pitched voices. LEVEL OF EVIDENCE: Level 4.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.